Evidence map›Paper›PMID 41194828›Full record

ArticleCureus2025

Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features Arising in the Thyroglossal Duct: A Case Report and Literature Review.

Manami Momii, Shingo Umemoto, Takenao Tei, Takashi Hirano

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Manami MomiiDepartment of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, Oita University, Yufu, JPN.
Shingo UmemotoDepartment of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, Oita University, Yufu, JPN.
Takenao TeiDepartment of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, Oita University, Yufu, JPN.
Takashi HiranoDepartment of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, Oita University, Yufu, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is a recently reclassified thyroid tumor characterized by low malignant potential and typically confined to the thyroid gland. Its occurrence in a thyroglossal duct remnant is exceedingly rare, with only a few cases reported. Herein, we describe the case of a 74-year-old man who presented with a painless, progressively enlarging midline anterior neck mass. Ultrasonography and contrast-enhanced computed tomography demonstrated a well-circumscribed cystic lesion along the thyroglossal duct tract. Fine-needle aspiration cytology revealed a follicular-patterned lesion, consistent with Bethesda category IV. The patient subsequently underwent surgical excision via the Sistrunk procedure. Histopathological examination showed a completely encapsulated follicular lesion with papillary-like nuclear features, without true papillae, capsular, or vascular invasion, thereby confirming the diagnosis of NIFTP arising in ectopic thyroid tissue. Given the absence of invasive features, no additional therapy was required, and no recurrence was observed at the six-month follow-up. This case highlights the diagnostic limitations of preoperative cytology in ectopic thyroid lesions and underscores the importance of complete surgical excision when malignancy cannot be definitively excluded.

Indexed as

fine-needle aspiration cytologynoninvasive follicular thyroid neoplasm with papillary-like nuclear featuressistrunk procedurethyroglossal duct cystthyroid cancer

Identifiers

PMID41194828
PMCPMC12585182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.